Tuesday June 25, 2019

Let’s Celebrate World Blood Donor Day!

Blood cannot be synthetically manufactured. Blood donated by donors is the ONLY source!

0
//
Let's Celebrate World Blood Donor Day!
Let's Celebrate World Blood Donor Day!

Dr. Sheetal Manrekar

Today (June 14) is World Blood Donor Day.

Donate blood. Save lives. Get healthier.

Blood and blood products obtained by blood donation can help save the lives of millions of people. Blood is required for medical problems like-

– Anaemia
– Trauma
– Complications during pregnancy and delivery
– Surgical emergencies
– Medical conditions like Thalassaemia, Sickle cell disease, Clotting factor deficiency (Hemophilia)
– Blood cancers
– Cancer patients on chemotherapy

Blood cannot be synthetically manufactured. Blood donated by donors is the ONLY source!

World Blood Donor Day.
World Blood Donor Day. Pixabay

Blood donation not only helps those in need but it also has certain health benefits for the blood donors.

It decreases blood viscosity (thickness of blood) and enables a better flow of blood in the body. This also prevents damage to the arteries and maintains a healthy heart and blood vessels.
It regulates iron levels in the blood. Presence of excess iron in the blood can be damaging to blood vessels due to oxidative stress.

It regulates blood regeneration. Replacement of the red cells takes 48 hours and complete replacement takes 1-2 months.
Lowers the risk of certain cancers (liver lung colon, stomach, throat).

Evaluations done before blood donation enable donors to get regular check-ups and monitor their health.

It provides a sense of fulfillment and optimism as you know you have done a good deed.

This article was originally published in Same Condition. SameCondition is an online platform for patients and people looking to connect with others dealing with same (medical) conditions.

 

 

Next Story

Scientists Working on Blood Test for Diagnostic of Chronic Fatigue

The scientists "stressed" the blood samples using salt, and then compared the responses. The results, they said, showed all the CFS patients' blood samples creating a clear spike, while those from healthy controls remained relatively stable.

0
Blood samples are seen at a lab in Durham, N.C., Sept. 17, 2013. VOA
  1. Scientists in the United States say they have taken a step toward developing a possible diagnostic test for chronic fatigue syndrome, a condition characterized by exhaustion and other debilitating symptoms.

Researchers at Stanford University School of Medicine said a pilot study of 40 people, half of whom were healthy and half of whom had the syndrome, showed their potential biomarker test correctly identified those who were ill.

Chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis or ME, is estimated to affect some 2.5 million people in the United States and as many as 17 million worldwide.

Symptoms include overwhelming fatigue, joint pain, headaches and sleep problems. No cause or diagnosis has yet been established and the condition can render patients bed- or house-bound for years.

blood
Researchers at Stanford University School of Medicine said a pilot study of 40 people, half of whom were healthy and half of whom had the syndrome, showed their potential biomarker test correctly identified those who were ill. Pixabay

The research, published Monday in the journal Proceedings of the National Academy of Sciences, analyzed blood samples from trial volunteers using a “nanoelectronic assay” — a test that measures changes in tiny amounts of energy as a proxy for the health of immune cells and blood plasma.

The scientists “stressed” the blood samples using salt, and then compared the responses. The results, they said, showed all the CFS patients’ blood samples creating a clear spike, while those from healthy controls remained relatively stable.

“We don’t know exactly why the cells and plasma are acting this way, or even what they’re doing,” said Ron Davis, a professor of biochemistry and of genetics who co-led the study.

“[But] we clearly see a difference in the way healthy and chronic fatigue syndrome immune cells process stress.”

Words of caution

blood
Researchers at Stanford University School of Medicine said a pilot study of 40 people, half of whom were healthy and half of whom had the syndrome, showed their potential biomarker test correctly identified those who were ill. Pixabay

Other experts not directly involved in this work cautioned, however, that its findings showed there is still a long way to go before a biomarker is found that can establish CFS diagnosis and distinguish it from other conditions with similar symptoms.

Also Read: After Three Decades, Japanese Emperor Akihito Will Abdicate His Throne

Simon Wessely, chair of psychiatry at King’s College London’s Institute of Psychiatry Psychology & Neuroscience, who has worked with CFS patients for many years, said the study was the latest of many attempts to find a biomarker for CFS, but had not been able to solve two key issues:

“The [first] issue is, can any biomarker distinguish CFS patients from those with other fatiguing illnesses? And second, is it measuring the cause, and not the consequence, of illness?” he said in an emailed comment. “This study does not provide any evidence that either has finally been achieved.” (VOA)